Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
It is the active ingredient in medications like Mounjaro (FDA-approved for Type 2 diabetes) and Zepbound (FDA-approved for chronic weight management)
Product liability claims against Novo Nordisk rest on several established legal theories: Failure to warn patients and healthcare providers about the risk of gastroparesis despite evidence suggesting Novo Nordisk knew or should have known about this severe complication Inadequate labeling that minimized the severity and permanence of gastrointestinal side effects Defective warnings that failed to communicate the risk of NAION and permanent vision loss to prescribing physicians Negligent testing and post-market surveillance that should have detected these patterns of serious adverse events earlier Breach of implied warranty that the medication was safe for its intended use when prescribed as directed The FDAs regulatory timeline supports plaintiff allegations that warnings came too late
Whether you've been denied or are preparing for prior authorization, you have options
Get a quick answer
FASEB J 11 : 11571168
US$ 28.73
US$ 25.07
US$ 26.61
US$ 25.24
